Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome
NCT ID: NCT05647850
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2023-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants' umbilical cord blood will be collected for testing, but will not receive any intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Respiratory Distress Syndrome(ARDS) in Neonates
NCT03227289
Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
NCT06188195
US and Neurodevelopmental Outcomes in the Neonatal Intensive Care Unit (NICU)
NCT05071508
Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD
NCT04905732
Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)
NCT03311165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline characteristics of all patients
No intervention
No intervention
General characteristics of the patients.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Respiratory distress syndrome(RDS), transient tachypnoea of the neonate (TTN), or congenital anomalies as a primary current acute respiratory condition
* Hereditary endocrine and metabolic diseases
* Incomplete records
1 Minute
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University-Town Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hui Liu
Attending physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hui Liu
Role: PRINCIPAL_INVESTIGATOR
University-Town Hospital of Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University-Town Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Women and Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shuqing Tang
Role: primary
Hui Liu
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
123456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.